Keywords: gpc, biotech, sales, dive, 1st-half, germany-based, saw
GPC Biotech's sales dive 41% for 1st-half 2004
Article | 16 August 2004
Germany-based GPC Biotech saw its revenues tumble 41% to 6.6 millioneuros ($7.9 million) for the first six months ended June 30, 2004, a result in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
